KRAS and pancreatic ductal adenocarcinoma: reported that Histone H4 acetylation levels were increased in pancreatic ductal adenocarcinomas harbouring Kras mutations prior to the premalignant lesion change, and acetyl‐CoA metabolism contributed to metabolic or epigenetic modification promoted pancreatic tumourigenesis.[25a] Furthermore, Yuan et al.